In this article, I describe how a professional courtesy afforded to me as a radiologist allowed me to circumvent my institution's typical care timelines after my first screening mammogram was abnormal. I underwent biopsy and received a phone call with the results within 24 hours of screening, leading me to recognize and reflect upon my own professional privilege as a physician. I explore the implications of this privilege, including the potential impact on healthcare disparities.
CSF-venous fistulas (CVFs), first described in 2014, represent an important cause of spontaneous intracranial hypotension (SIH). CVFs can be challenging to detect on conventional anatomic imaging because, unlike other types of spinal CSF leak, they do not typically result in pooling of fluid in the epidural space, and imaging signs of CVF may be subtle. Specialized myelographic techniques have been developed to help with CVF identification, but these techniques are not yet widely disseminated. T...
#1Justin G. Yoon(Case Western Reserve University)H-Index: 1
#2Daniel A. Smith(University Hospitals of Cleveland)H-Index: 4
Last. Nikhil H. Ramaiya(University Hospitals of Cleveland)H-Index: 12
view all 0 authors...
Chimeric antigen receptor-engineer (CAR) T-cell therapy is a promising novel immunotherapy that has the potential to revolutionize cancer treatment. With four CAR T-cell therapies receiving FDA approval within the last 5 years, the role of CAR T-cells is anticipated to continue to evolve and expand. However, various aspects of CAR T-cell therapies remain poorly understood, and the therapies are associated with severe side effects [including cytokine release syndrome (CRS) and immune effector cel...
This Editorial Comment discusses the following AJR article: Impact of Dose Reduction Strategies on Image Quality of Coronary CTA in Real World Clinical Practice: A Subanalysis of PROTECTION VI Regi...
Last. Ukihide Tateishi(Tokyo Medical and Dental University)H-Index: 51
view all 0 authors...
Background: Pancreatic ductal adenocarcinoma (PDAC) is highly lethal, partly due to challenges in early diagnosis. However, the prognosis for earlier stages (carcinoma in situ or stage T1a invasive carcinoma) is relatively favorable. Objective: To investigate findings of an earlier diagnosis of PDAC on pre-diagnostic CT examinations performed at least one year before the diagnosis of clinical stage I PDAC. Methods: This retrospective study included 103 patients with clinical stage I PDAC and a p...
OBJECTIVE. The potential for significant disparities exists in the setting of increased adoption of prostate MRI. We sought to assess temporal trends in the utilization of MRI before prostate biops...